<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">SAGE Open Med Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">SAGE Open Med Case Rep</journal-id><journal-id journal-id-type="publisher-id">SCO</journal-id><journal-id journal-id-type="hwp">spsco</journal-id><journal-title-group><journal-title>SAGE Open Medical Case Reports</journal-title></journal-title-group><issn pub-type="epub">2050-313X</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage UK: London, England</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6542112</article-id><article-id pub-id-type="doi">10.1177/2050313X19852539</article-id><article-id pub-id-type="publisher-id">10.1177_2050313X19852539</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Maternal Loeys&#8211;Dietz syndrome (transforming growth factor ligand 2) in a twin pregnancy: Case report and discussion</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6765-7646</contrib-id><name><surname>Bashari</surname><given-names>Homira</given-names></name><xref ref-type="aff" rid="aff1-2050313X19852539">1</xref><xref ref-type="corresp" rid="corresp1-2050313X19852539"/></contrib><contrib contrib-type="author"><name><surname>Brooks</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff1-2050313X19852539">1</xref><xref ref-type="aff" rid="aff2-2050313X19852539">2</xref></contrib><contrib contrib-type="author"><name><surname>O&#8217;Brien</surname><given-names>Orla</given-names></name><xref ref-type="aff" rid="aff1-2050313X19852539">1</xref></contrib><contrib contrib-type="author"><name><surname>Brennecke</surname><given-names>Shaun</given-names></name><xref ref-type="aff" rid="aff1-2050313X19852539">1</xref><xref ref-type="aff" rid="aff2-2050313X19852539">2</xref><xref ref-type="aff" rid="aff3-2050313X19852539">3</xref></contrib><contrib contrib-type="author"><name><surname>Zentner</surname><given-names>Dominica</given-names></name><xref ref-type="aff" rid="aff4-2050313X19852539">4</xref><xref ref-type="aff" rid="aff5-2050313X19852539">5</xref></contrib></contrib-group><aff id="aff1-2050313X19852539"><label>1</label>Maternity Services, The Royal Women&#8217;s Hospital, Melbourne, VIC, Australia</aff><aff id="aff2-2050313X19852539"><label>2</label>Department of Maternal Fetal Medicine, The Royal Women&#8217;s Hospital, Melbourne, VIC, Australia</aff><aff id="aff3-2050313X19852539"><label>3</label>Department of Obstetrics and Gynaecology, University of Melbourne and The Royal Women&#8217;s Hospital, Melbourne, VIC, Australia</aff><aff id="aff4-2050313X19852539"><label>4</label>Departments of Cardiology and Genetic Medicine, The Royal Melbourne Hospital, Melbourne, VIC, Australia</aff><aff id="aff5-2050313X19852539"><label>5</label>Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne and Royal Melbourne Hospital Clinical School, Melbourne, VIC, Australia</aff><author-notes><corresp id="corresp1-2050313X19852539">Homira Bashari, Maternity Services, The Royal Women&#8217;s Hospital, Melbourne, Parkville, VIC, Australia. Email: <email>homira.bashari@thewomens.org.au</email></corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>7</volume><elocation-id>2050313X19852539</elocation-id><history><date date-type="received"><day>19</day><month>1</month><year>2019</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>&#169; The Author(s) 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><p>Loeys&#8211;Dietz syndrome is a rare autosomal dominant connective tissue disorder. Pregnant women with Loeys&#8211;Dietz syndrome are at increased risk of serious vascular and visceral complications, including aortic dissection and uterine rupture. Multidisciplinary tertiary management aims to mitigate such complications by preconception counselling and vascular assessment, medical therapy, regular echocardiography in pregnancy and joint decision-making re-mode and timing of delivery. We report an in vitro fertilisation twin pregnancy in a woman with Loeys&#8211;Dietz syndrome first seen at our institution at 26&#8201;weeks&#8217; gestation. After monitoring via serial echocardiograms, caesarean delivery occurred at 30&#8201;+&#8201;1&#8201;weeks&#8217; gestation to allow planned delivery with suspected fetal growth restriction before uterine distension was considered an indication. The patient was discharged on Day 9 with a planned early aortic root replacement due to an increase in diameter from 39 to 43&#8201;mm, followed by the discharge of twin boys at term equivalent.</p></abstract><kwd-group><kwd>Obstetrics/gynaecology</kwd><kwd>women&#8217;s health</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>January-December 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="section1-2050313X19852539"><title>Introduction</title><p>Loeys&#8211;Dietz syndrome (LDS; Online Mendelian Inheritance in Man number 614816) is a rare autosomal dominant connective tissue disorder<sup><xref rid="bibr1-2050313X19852539" ref-type="bibr">1</xref></sup> most commonly caused by mutations in transforming growth factor receptors 1/2 (<italic>TGFBR1/2</italic>),<sup><xref rid="bibr2-2050313X19852539" ref-type="bibr">2</xref>,<xref rid="bibr3-2050313X19852539" ref-type="bibr">3</xref></sup> as well as in decapentaplegic homolog 2/3 (<italic>SMAD2/3</italic>) and transforming growth factor ligand 2/3 (<italic>TGFB2/3</italic>).<sup><xref rid="bibr3-2050313X19852539" ref-type="bibr">3</xref></sup> Initially described as a triad of arterial tortuosity, hypertelorism and bifid uvula&#8201;&#177;&#8201;cleft palate,<sup><xref rid="bibr1-2050313X19852539" ref-type="bibr">1</xref></sup> LDS has a tendency for more aggressive aortic dissection (including in normally sized vessels), extra-aortic vascular involvement and a wide phenotypic expression including individuals lacking the originally described clinical features of the syndrome.<sup><xref rid="bibr3-2050313X19852539" ref-type="bibr">3</xref></sup> Pregnant women with LDS are at higher risk of aortic aneurysms and uterine rupture.<sup><xref rid="bibr4-2050313X19852539" ref-type="bibr">4</xref></sup> Counselling, imaging of the entire vascular tree (head to pelvis, ideally by magnetic resonance imaging (MRI)), identification of a genetic mutation with the option of pre-implantation or early-pregnancy genetic diagnosis and transition to medication that is acceptable in pregnancy should ideally lead to preconception.<sup><xref rid="bibr5-2050313X19852539" ref-type="bibr">5</xref></sup> It is important for affected women to understand that aortic dimensions alone do not predict complications and that pregnancy remains a time of increased risk irrespective of investigation results. Women should be educated about typical symptoms and advised to call an ambulance and state &#8216;I am having an aortic dissection&#8217; if these occur. In pregnancy, regular imaging with echocardiography of the aortic root and ascending aorta should be undertaken.<sup><xref rid="bibr4-2050313X19852539" ref-type="bibr">4</xref>,<xref rid="bibr6-2050313X19852539" ref-type="bibr">6</xref></sup></p><p>We describe a twin delivery in a patient with LDS and a mutation that has been rarely reported in association with pregnancy. A dichorionic diamniotic (DCDA) twin pregnancy was conceived via in vitro fertilisation (IVF). Delivery occurred via planned caesarean section (CS) at 30&#8201;+&#8201;1&#8201;weeks&#8217; gestation due to concerns regarding fetal welfare secondary to placental insufficiency and avoidance of unplanned delivery.</p></sec><sec sec-type="cases" id="section2-2050313X19852539"><title>Case report</title><p>A 37-year-old primigravida with LDS was referred to our tertiary level maternity hospital at 26&#8201;weeks&#8217; gestation after IVF elsewhere resulted in a DCDA twin pregnancy.</p><p>Genetic testing in 2015 made the diagnosis of LDS due to a <italic>TGFB2</italic> exon 6 c.979 C&#8201;&gt;&#8201;T mutation. Maternal past history included talipes equinovarus requiring operations resulting in chronic pain and treatment with &#215;2 sacral nerve stimulators, diplopia, asthma, depression, and multiple hernia repairs.</p><p>Her family history identified eight affected individuals, with one aortic dissection in an aunt aged 49 (aortic root diameter 45&#8201;mm), multiple aortic operations, and two gene-positive relatives with reportedly uncomplicated vaginal and caesarean deliveries.</p><p>Regular cardiology review with annual echocardiograms had been undertaken elsewhere since her teenage years. Before pregnancy, the aortic root diameter was 39&#8201;mm. No prior imaging of the entire vascular tree had been undertaken and sacral nerve stimulators precluded MRI. Spinal computed tomography (CT) 3&#8201;years earlier suggested sacral dural ectasia.</p><p>During pregnancy, echocardiograms showed an increase in the aortic root diameter from 39 to 42&#8201;mm (<xref rid="table1-2050313X19852539" ref-type="table">Table 1</xref>).</p><table-wrap id="table1-2050313X19852539" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Serial echocardiogram of heart over the course of pregnancy.</p></caption><alternatives><graphic xlink:href="10.1177_2050313X19852539-table1"/></alternatives></table-wrap><p>Pre-pregnancy irbesartan 300&#8201;mg once daily had been transitioned to labetalol 100&#8201;mg twice daily due to the contraindication of angiotensin receptor blockers in pregnancy. At 28&#8201;weeks&#8217; gestation, this was increased to 200&#8201;mg three times a day with the aim of reducing the heart rate to 60&#8211;70 beats per minute.</p><p>Inpatient management commenced at 28&#8201;weeks&#8217; gestation due to suspected growth restriction in Twin 2 (absent-end diastolic flow in the umbilical artery Doppler). Although delivery was initially planned via CS at 32&#8211;34&#8201;weeks&#8217; gestation due to concerns around the theoretical risk of uterine rupture, the caesarean actually occurred at 30&#8201;+&#8201;1&#8201;weeks&#8217; gestation due to fetal welfare and desire to avoid unplanned delivery. Prior to delivery, betamethasone was given to promote fetal lung maturity. Twin boys (birth weights of 1430&#8201;g and 1150&#8201;g) were delivered and admitted to neonatal intensive care. An atonic postpartum haemorrhage (PPH) of 1.3&#8201;L required oxytocin infusion and, despite the relative contraindication, 250&#8201;&#956;g intramuscular ergometrine for management. She was subsequently transferred to the cardiology coronary care unit for 48&#8201;h of planned monitoring. Echocardiogram on Day 1 reported an aortic root dilatation of 43&#8201;mm, confirmed with a CT angiogram showing a trans-sinus (cusp-cusp) diameter of 43&#8201;mm. She was discharged to the postnatal ward on Day 3, and a repeat echocardiogram on Day 8 showed a stable aortic root diameter of 43&#8201;mm.</p><p>Although animal data in a mouse Marfan Syndrome (MFS) model has raised the possibility that breastfeeding increases the risk of aortic dissection,<sup><xref rid="bibr7-2050313X19852539" ref-type="bibr">7</xref></sup> our patient elected to express her breast milk after discussion of the potential theoretical risk.</p><p>After delivery, medication was changed to metoprolol 125&#8201;mg twice daily. The postpartum course was uneventful with good wound healing, and she was discharged home on Day 9 with a plan for a repeat echocardiogram and clinical review at 6&#8201;weeks postpartum with subsequent early aortic root repair planned. A postnatal cerebral CT revealed the arterial tortuosity considered characteristic for the condition (<xref ref-type="fig" rid="fig1-2050313X19852539">Figure 1</xref>).</p><fig id="fig1-2050313X19852539" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Postnatal cerebral CT angiogram.</p></caption><graphic xlink:href="10.1177_2050313X19852539-fig1"/></fig></sec><sec sec-type="discussion" id="section3-2050313X19852539"><title>Discussion</title><p>Reports of LDS and pregnancy are limited, and the largest series only includes the commonest mutations.<sup><xref rid="bibr8-2050313X19852539" ref-type="bibr">8</xref></sup> This case report highlights the challenges of managing women with rare conditions. Preconception counselling and embryo transfer occurred at another medical service. The decision to not undergo pre-implantation genetic diagnosis (PGD) was made by the patient. Double embryo transfer would not be advised in conditions with propensity for uterine rupture.</p><p>There is little published on the management of pregnancy in these patients. Preconception, vascular system assessment is recommended via CT or MRI. Prophylactic preconception aortic root replacement is advised; however, there is a lack of consensus regarding the precise indication for such surgery, and most consensus statements refer to MFS rather than specifically to LDS. European guidelines suggest preconception aortic root replacement at 45&#8201;mm or greater.<sup><xref rid="bibr9-2050313X19852539" ref-type="bibr">9</xref></sup> North American guidelines<sup><xref rid="bibr10-2050313X19852539" ref-type="bibr">10</xref></sup> suggest preconception surgery at greater than 40&#8201;mm and a Canadian position statement suggests preconception surgery at 41&#8211;45&#8201;mm.<sup><xref rid="bibr11-2050313X19852539" ref-type="bibr">11</xref></sup> In contrast, the 2018 European guidelines advise against pregnancy if 45&#8201;mm or greater.<sup><xref rid="bibr12-2050313X19852539" ref-type="bibr">12</xref></sup> Patients with LDS can have dural ectasia and cervical spine abnormalities.<sup><xref rid="bibr6-2050313X19852539" ref-type="bibr">6</xref>,<xref rid="bibr13-2050313X19852539" ref-type="bibr">13</xref></sup> Pre-pregnancy imaging of the spine allows anaesthetic planning.</p><p>As LDS is an autosomal dominant disorder, there is a 50% risk that a fetus will be affected if either parent has the condition. PGD or early-pregnancy testing potentially allow antenatal identification of affected pregnancies.<sup><xref rid="bibr4-2050313X19852539" ref-type="bibr">4</xref></sup></p><p>Multidisciplinary care should be provided in a tertiary-level maternity hospital with clear plans for preconception, antenatal, peri-delivery and postnatal management between specialties. Regular follow-up, close blood pressure monitoring and use of &#946;-blockers to maintain low normal blood pressure and heart rate are crucial.<sup><xref rid="bibr6-2050313X19852539" ref-type="bibr">6</xref></sup> Monthly assessment of aortic diameter via echocardiography is recommended.<sup><xref rid="bibr4-2050313X19852539" ref-type="bibr">4</xref></sup></p><p>The risk of vaginal delivery versus CS is difficult to quantify with very little evidence available, particularly in multiple pregnancy and with this mutation. The most recent European guidelines suggest vaginal delivery in patients with aortic connective tissue disorders if the aortic diameter is less than 40&#8201;mm, which this mode may be considered between 40 and 45&#8201;mm and that CS should be considered when it is greater than 45&#8201;mm.<sup><xref rid="bibr12-2050313X19852539" ref-type="bibr">12</xref></sup> Preterm CS is often undertaken due to reports of uterine rupture and the hypothetical risk of aortic dissection.<sup><xref rid="bibr2-2050313X19852539" ref-type="bibr">2</xref>,<xref rid="bibr4-2050313X19852539" ref-type="bibr">4</xref></sup></p><p>In the case of PPH, tranexamic acid, misoprostol and surgical procedures are recommended. In general, ergometrine is usually contraindicated due to concerns about resultant hypertension; however, it is recognised that at times, blood loss may be severe enough to warrant its use, as occurred in this case. To date, there is no established guideline concerning the use or type of oxytocin for the management of the third stage of labour in women with LDS. However, the accepted consensus is oxytocin infusion rather than bolus administration.<sup><xref rid="bibr4-2050313X19852539" ref-type="bibr">4</xref></sup></p><p>Increased risk of aortic dissection persists for some weeks post-delivery.<sup><xref rid="bibr2-2050313X19852539" ref-type="bibr">2</xref>,<xref rid="bibr14-2050313X19852539" ref-type="bibr">14</xref><xref rid="bibr15-2050313X19852539" ref-type="bibr"/>&#8211;<xref rid="bibr16-2050313X19852539" ref-type="bibr">16</xref></sup> Extended inpatient monitoring, repeat aortic root imaging, and maintaining normal blood pressure are important.<sup><xref rid="bibr4-2050313X19852539" ref-type="bibr">4</xref></sup></p></sec><sec sec-type="conclusions" id="section4-2050313X19852539"><title>Conclusion</title><p>LDS is a rare condition with a significant risk of pregnancy-related complications. Preconception counselling and assessment is strongly recommended. Pregnancy should be managed by a multidisciplinary team in a tertiary-level maternity hospital with regular aortic root imaging and &#946;-blockade. Management of these women is limited by the paucity of data. This case is reported to add to the body of experience. Sharing of pregnancy data, regardless of outcomes, ideally through a registry is the likely best way to ascertain the true risks and reasonable management options in such rare maternal diseases.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold>Declaration of conflicting interests:</bold> The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.</p></fn><fn fn-type="other"><p><bold>Ethical approval:</bold> Our institution does not require ethical approval for reporting anonymised individual cases or case series.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) received no financial support for the research, authorship and/or publication of this article.</p></fn><fn fn-type="other"><p><bold>Informed consent:</bold> Written informed consent was obtained from the patient for their anonymized information to be published in this article.</p></fn><fn fn-type="other"><p><bold>ORCID iD:</bold> Homira Bashari <inline-graphic xlink:href="10.1177_2050313X19852539-img1.jpg"/>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-6765-7646">https://orcid.org/0000-0001-6765-7646</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-2050313X19852539"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loeys</surname><given-names>BL</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Neptune</surname><given-names>ER</given-names></name><etal>et al</etal></person-group>
<article-title>A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2</article-title>. <source>Nat Genet</source>
<year>2005</year>; <volume>37</volume>(<issue>3</issue>): <fpage>275</fpage>&#8211;<lpage>281</lpage>.<pub-id pub-id-type="pmid">15731757</pub-id></mixed-citation></ref><ref id="bibr2-2050313X19852539"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loeys</surname><given-names>BL</given-names></name><name><surname>Schwarze</surname><given-names>U</given-names></name><name><surname>Holm</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Aneurysm syndromes caused by mutations in the TGF-beta receptor</article-title>. <source>N Engl J Med</source>
<year>2006</year>; <volume>355</volume>(<issue>8</issue>): <fpage>788</fpage>&#8211;<lpage>798</lpage>.<pub-id pub-id-type="pmid">16928994</pub-id></mixed-citation></ref><ref id="bibr3-2050313X19852539"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schepers</surname><given-names>D</given-names></name><name><surname>Tortora</surname><given-names>G</given-names></name><name><surname>Morisaki</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Amutation update on the LDS-associated genes TGFB2/3 and SMAD2/3</article-title>. <source>Hum Mutat</source>
<year>2018</year>; <volume>39</volume>(<issue>5</issue>): <fpage>621</fpage>&#8211;<lpage>634</lpage>.<pub-id pub-id-type="pmid">29392890</pub-id></mixed-citation></ref><ref id="bibr4-2050313X19852539"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frise</surname><given-names>CJ</given-names></name><name><surname>Pitcher</surname><given-names>A</given-names></name><name><surname>Mackillop</surname><given-names>L.</given-names></name></person-group>
<article-title>Loeys&#8211;Dietz syndrome and pregnancy: the first ten years</article-title>. <source>Int J Cardiol</source>
<year>2017</year>; <volume>226</volume>: <fpage>21</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="pmid">27780078</pub-id></mixed-citation></ref><ref id="bibr5-2050313X19852539"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zentner</surname><given-names>D</given-names></name><name><surname>West</surname><given-names>M</given-names></name><name><surname>Ades</surname><given-names>LC</given-names></name><etal>et al</etal></person-group>
<article-title>Update on the diagnosis and management of inherited aortopathies, including Marfan syndrome</article-title>. <source>Heart Lung Circ</source>
<year>2017</year>; <volume>26</volume>(<issue>6</issue>): <fpage>536</fpage>&#8211;<lpage>544</lpage>.<pub-id pub-id-type="pmid">28161018</pub-id></mixed-citation></ref><ref id="bibr6-2050313X19852539"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>MacCarrick</surname><given-names>G</given-names></name><name><surname>Black</surname><given-names>JH</given-names><suffix>3rd</suffix></name><name><surname>Bowdin</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Loeys&#8211;Dietz syndrome: a primer for diagnosis and management</article-title>. <source>Genet Med</source>
<year>2014</year>; <volume>16</volume>(<issue>8</issue>): <fpage>576</fpage>&#8211;<lpage>587</lpage>.<pub-id pub-id-type="pmid">24577266</pub-id></mixed-citation></ref><ref id="bibr7-2050313X19852539"><label>7</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Habashi</surname><given-names>JP</given-names></name><name><surname>Gallo</surname><given-names>EM</given-names></name><name><surname>Huso</surname><given-names>N</given-names></name><etal>et al</etal></person-group>
<article-title>A causative role for oxytocin in pregnancy-induced aortic dissection in Marfan syndrome mouse models</article-title>. In: <source>Presented at the Annual Meeting of the American Society of Human Genetics</source>, <publisher-name>San Diego</publisher-name>, <publisher-loc>CA</publisher-loc>, <day>12</day>
<month>10</month>
<year>2014</year>.</mixed-citation></ref><ref id="bibr8-2050313X19852539"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jondeau</surname><given-names>G</given-names></name><name><surname>Ropers</surname><given-names>J</given-names></name><name><surname>Regalado</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>International registry of patients carrying TGFBR1 or TGFBR2 mutations: results of the Montalcino Aortic Consortium</article-title>. <source>Circ Cardiovasc Genet</source>
<year>2016</year>; <volume>9</volume>(<issue>6</issue>): <fpage>548</fpage>&#8211;<lpage>558</lpage>.<pub-id pub-id-type="pmid">27879313</pub-id></mixed-citation></ref><ref id="bibr9-2050313X19852539"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Erbel</surname><given-names>R</given-names></name><name><surname>Aboyans</surname><given-names>V</given-names></name><name><surname>Boileau</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult</article-title>. <source>Eur Heart J</source>
<year>2014</year>; <volume>35</volume>(<issue>41</issue>): <fpage>2873</fpage>&#8211;<lpage>2926</lpage>.<pub-id pub-id-type="pmid">25173340</pub-id></mixed-citation></ref><ref id="bibr10-2050313X19852539"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hiratzka</surname><given-names>LF</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Beckman</surname><given-names>JA</given-names></name><etal>et al</etal></person-group>
<article-title>2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine</article-title>. <source>Circ</source>
<year>2010</year>; <volume>121</volume>(<issue>13</issue>): <fpage>266</fpage>&#8211;<lpage>369</lpage>.</mixed-citation></ref><ref id="bibr11-2050313X19852539"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boodhwani</surname><given-names>M</given-names></name><name><surname>Andelfinger</surname><given-names>G</given-names></name><name><surname>Leipsic</surname><given-names>J</given-names></name><etal>et al</etal></person-group>
<article-title>Canadian cardiovascular society position statement on the management of thoracic aortic disease</article-title>. <source>Can J Cardiol</source>
<year>2014</year>; <volume>30</volume>(<issue>6</issue>): <fpage>577</fpage>&#8211;<lpage>589</lpage>.<pub-id pub-id-type="pmid">24882528</pub-id></mixed-citation></ref><ref id="bibr12-2050313X19852539"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Regitz-Zagrosek</surname><given-names>V</given-names></name><name><surname>Roos-Hesselink</surname><given-names>JW</given-names></name><name><surname>Bauersachs</surname><given-names>J</given-names></name><etal>et al</etal></person-group>
<article-title>2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy</article-title>. <source>Eur Heart J</source>
<year>2018</year>; <volume>39</volume>: <fpage>3165</fpage>&#8211;<lpage>3241</lpage>.<pub-id pub-id-type="pmid">30165544</pub-id></mixed-citation></ref><ref id="bibr13-2050313X19852539"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cronin</surname><given-names>J</given-names></name><name><surname>Bazick</surname><given-names>HC</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Anaesthesia considerations for caesarean delivery in a patient with Loeys&#8211;Dietz syndrome</article-title>. <source>Anesth Analg Case Rep</source>
<year>2015</year>; <volume>4</volume>(<issue>4</issue>): <fpage>47</fpage>&#8211;<lpage>48</lpage>.</mixed-citation></ref><ref id="bibr14-2050313X19852539"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kunishige</surname><given-names>H</given-names></name><name><surname>Ishibashi</surname><given-names>Y</given-names></name><name><surname>Kawasaki</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Surgical treatment for acute type A aortic dissection during pregnancy (16 weeks) with Loeys&#8211;Dietz syndrome</article-title>. <source>Gen Thorac Cardiovasc Surg</source>
<year>2012</year>; <volume>60</volume>(<issue>11</issue>): <fpage>764</fpage>&#8211;<lpage>767</lpage>.<pub-id pub-id-type="pmid">22627960</pub-id></mixed-citation></ref><ref id="bibr15-2050313X19852539"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Braverman</surname><given-names>AC</given-names></name><name><surname>Moon</surname><given-names>MR</given-names></name><name><surname>Geraghty</surname><given-names>P</given-names></name><etal>et al</etal></person-group>
<article-title>Pregnancy after aortic root replacement in Loeys&#8211;Dietz syndrome: high risk of aortic dissection</article-title>. <source>Am J Med Genet A</source>
<year>2016</year>; <volume>170</volume>(<issue>8</issue>): <fpage>2177</fpage>&#8211;<lpage>2180</lpage>.<pub-id pub-id-type="pmid">27125181</pub-id></mixed-citation></ref><ref id="bibr16-2050313X19852539"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fujita</surname><given-names>D</given-names></name><name><surname>Takeda</surname><given-names>N</given-names></name><name><surname>Morita</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>A novel mutation of TGFBR2 causing Loeys&#8211;Dietz syndrome complicated with pregnancy-related fatal cervical arterial dissections</article-title>. <source>Int J Cardiol</source>
<year>2015</year>; <volume>201</volume>: <fpage>288</fpage>&#8211;<lpage>290</lpage>.<pub-id pub-id-type="pmid">26301661</pub-id></mixed-citation></ref></ref-list></back></article>